Dr Lalchandani Labs share news and announcements

BSE: 541299Healthcare ServicesSmall Cap

₹6.96₹0.19 (2.66%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹7.15.

52-week range of traded prices to 23 Oct 2026

₹5.81Low, 9 Oct 2026₹23.69High, 12 Jan 2026

Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.

Market cap: ₹6.01 Cr4,613th largest listed
P/E: 94.7
P/B: 0.4
Dividend yield: Nonein the last 12 months
ROE: 0.5%
Debt to equity: 0.15
Volume, BSE: 44,000

Dr Lalchandani Labs share news and announcements

273 announcements, routine notices left out, newest first. Page 4 of 6.

Nov 2021
- 3 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
Oct 2021
- 15 Oct · Shareholding for the Period Ended September 30, 2021
  Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....
- 11 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2021
Aug 2021
- 18 Aug · Management
  DR LALCHANDANI LABS LIMITED hereby inform that M/s Heena Taneja and Associates (Practicing Company Secretaries) has appointed as a Secretarial Auditor along with Scrutinizer for the Financial .... (opens in a new tab)
Jul 2021
- 12 Jul · Results
  Dr Lalchandani Labs Limited wish to inform you that the Board of Directors of the Company at its meeting held today, inter alia has transacted the following: 1. Statement showing the .... (opens in a new tab)
- 12 Jul · Board meeting
  Dr Lalchandani Labs Limited wish to inform you that the Board of Directors of the Company at its meeting held today, inter alia has transacted the following: 1. Statement showing the .... (opens in a new tab)
- 6 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 5 Jul · Board meeting
  Meeting on 12 Jul 2021: audited results
- 5 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 12/07/2021 ,inter alia, to consider and approve 1. Audited Financial Results .... (opens in a new tab)
Jun 2021
- 30 Jun · Board meeting
  Board Meeting to be held on 30/06/2021 Stands Cancelled. (opens in a new tab)
- 25 Jun · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve Dr Lalchandani Labs Limited .... (opens in a new tab)
Apr 2021
- 10 Apr
  Certificate Issued In Compliance Of Regulation 40(9) of the Provision of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 31st March, 2021. (opens in a new tab)
- 9 Apr · Shareholding for the Period Ended March 31, 2021
  Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....
- 7 Apr · Compliances- Compliance Certificate For The Period Ended March 31, 2021
  Compliances- Compliance Certificate under Regulation 7(3) for the period ended March 31, 2021. (opens in a new tab)
- 7 Apr · Statement Of Investor Complaints For The Quarter Ended March 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2021
- 13 Mar · Management
  Dr Lalchandani Labs Limited wish to inform BSE that M/s Vikas Bagga & Co. has been appointed as an Internal Auditor of the Company in a meeting held on 13th March 2021. (opens in a new tab)
- 8 Mar · Announcement Regarding Approval For COVID-19 Vaccination Centre.
  Dr Lalchandani Labs Limited are hereby glad to announce that we have associated with the government on the nationwide vaccination program, and for same got the approval from central and .... (opens in a new tab)
Jan 2021
- 19 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2020
- 12 Dec · Results
  We hereby submitting the Revised Un-Audited Financial Results for the half year ended September 30, 2020. 1. Un-Audited Financial Results for the half year ended as on September 30, 2020. .... (opens in a new tab)
Nov 2020
- 13 Nov · Results
  We are hereby submitting the Unaudited Financial Results along with Limited Review Report for the half year ended on 30th September, 2020. 1. Un-audited Financial Results for the .... (opens in a new tab)
- 13 Nov · Board meeting
  Outcome Of Board Meeting (opens in a new tab)
- 6 Nov · Board meeting
  Meeting on 13 Nov 2020: half yearly results
- 6 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 13/11/2020 ,inter alia, to consider and approve Dr Lalchandani Labs Limited .... (opens in a new tab)
Oct 2020
- 26 Oct · Certificate Issued In Compliance Of Regulation 40(9) Of The Provision Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 30Th September, 2020
  Certificate Issued In Compliance Of Regulation 40(9) Of The Provision Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 30th September, 2020. (opens in a new tab)
- 20 Oct · Shareholding for the Period Ended September 30, 2020
  Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....
- 13 Oct
  Compliance Certificate For The Period Ended 30th September, 2020. (opens in a new tab)
- 12 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 9 Oct · Legal
  Clarification is enclosed. (opens in a new tab)
- 9 Oct · Legal
  Exchange has sought clarification from Dr Lalchandani Labs Ltd on October 9, 2020, with reference to Movement in Price. The reply is awaited.
Sep 2020
Aug 2020
- 28 Aug · Results
  We hereby submitting the Revised Audited Financial Results for the half year and year ended March 31, 2020. 1. Audited Financial Results for the half year and year ended as on .... (opens in a new tab)
Jul 2020
- 29 Jul · Management
  Intimation is hereby given that Dr Lalchandani Labs Limited has appointed M/S. Heena Taneja And Associates as its Secretarial Auditor and Scrutinizer for Financial Year 2019-2020. (opens in a new tab)
- 28 Jul · Results
  Dr Lalchandani Labs Limited wish to inform you that the Board of the Company at its meeting held today, inter alia has transacted the following: 1. Statement showing the Audited .... (opens in a new tab)
- 28 Jul · Board meeting
  Dr Lalchandani Labs Limited wish to inform you that the Board of the Company at its meeting held today, inter alia has transacted the following: 1. Statement showing the Audited .... (opens in a new tab)
- 23 Jul · Board meeting
  Meeting on 28 Jul 2020: audited results

Dr Lalchandani Labs share news and announcements

Nov 2021

Oct 2021

Sep 2021

Aug 2021

Jul 2021

Jun 2021

Apr 2021

Mar 2021

Jan 2021

Dec 2020

Nov 2020

Oct 2020

Sep 2020

Aug 2020

Jul 2020